nodes	percent_of_prediction	percent_of_DWPC	metapath
Zaleplon—Facial paralysis—Carmustine—malignant glioma	0.0167	0.0259	CcSEcCtD
Zaleplon—Hyperacusis—Temozolomide—malignant glioma	0.0138	0.0214	CcSEcCtD
Zaleplon—VIIth nerve paralysis—Carmustine—malignant glioma	0.013	0.0201	CcSEcCtD
Zaleplon—Cerebral ischaemia—Temozolomide—malignant glioma	0.0106	0.0165	CcSEcCtD
Zaleplon—Tongue discolouration—Temozolomide—malignant glioma	0.0106	0.0165	CcSEcCtD
Zaleplon—TSPO—blood vessel—malignant glioma	0.00951	0.053	CbGeAlD
Zaleplon—Myasthenia—Carmustine—malignant glioma	0.00847	0.0131	CcSEcCtD
Zaleplon—Parosmia—Temozolomide—malignant glioma	0.00793	0.0123	CcSEcCtD
Zaleplon—Hypokinesia—Carmustine—malignant glioma	0.00789	0.0122	CcSEcCtD
Zaleplon—Apathy—Temozolomide—malignant glioma	0.0072	0.0112	CcSEcCtD
Zaleplon—Flat affect—Temozolomide—malignant glioma	0.00714	0.0111	CcSEcCtD
Zaleplon—Stupor—Carmustine—malignant glioma	0.00713	0.011	CcSEcCtD
Zaleplon—Scotoma—Carmustine—malignant glioma	0.00701	0.0109	CcSEcCtD
Zaleplon—Vaginal haemorrhage—Temozolomide—malignant glioma	0.00695	0.0108	CcSEcCtD
Zaleplon—Menorrhagia—Temozolomide—malignant glioma	0.00695	0.0108	CcSEcCtD
Zaleplon—Hepatotoxicity—Carmustine—malignant glioma	0.00689	0.0107	CcSEcCtD
Zaleplon—Scotoma—Temozolomide—malignant glioma	0.00677	0.0105	CcSEcCtD
Zaleplon—Hepatotoxicity—Temozolomide—malignant glioma	0.00666	0.0103	CcSEcCtD
Zaleplon—Hyperaesthesia—Temozolomide—malignant glioma	0.00656	0.0102	CcSEcCtD
Zaleplon—Speech disorder—Carmustine—malignant glioma	0.00619	0.00959	CcSEcCtD
Zaleplon—GABRB2—brainstem—malignant glioma	0.00614	0.0343	CbGeAlD
Zaleplon—Speech disorder—Temozolomide—malignant glioma	0.00598	0.00927	CcSEcCtD
Zaleplon—Disturbance in attention—Temozolomide—malignant glioma	0.00594	0.0092	CcSEcCtD
Zaleplon—Breast pain—Temozolomide—malignant glioma	0.0059	0.00914	CcSEcCtD
Zaleplon—Thinking abnormal—Carmustine—malignant glioma	0.00582	0.00901	CcSEcCtD
Zaleplon—TSPO—embryo—malignant glioma	0.00567	0.0316	CbGeAlD
Zaleplon—Leukocytosis—Carmustine—malignant glioma	0.00567	0.00878	CcSEcCtD
Zaleplon—Hyperbilirubinaemia—Temozolomide—malignant glioma	0.00566	0.00877	CcSEcCtD
Zaleplon—GABRA2—brainstem—malignant glioma	0.00561	0.0313	CbGeAlD
Zaleplon—Gait disturbance—Carmustine—malignant glioma	0.00545	0.00845	CcSEcCtD
Zaleplon—GABRG2—telencephalon—malignant glioma	0.00545	0.0304	CbGeAlD
Zaleplon—GABRB2—telencephalon—malignant glioma	0.00545	0.0304	CbGeAlD
Zaleplon—GABRA1—brainstem—malignant glioma	0.00543	0.0303	CbGeAlD
Zaleplon—Coordination abnormal—Carmustine—malignant glioma	0.00542	0.0084	CcSEcCtD
Zaleplon—Pulmonary embolism—Carmustine—malignant glioma	0.00532	0.00825	CcSEcCtD
Zaleplon—Gait disturbance—Temozolomide—malignant glioma	0.00527	0.00817	CcSEcCtD
Zaleplon—Coordination abnormal—Temozolomide—malignant glioma	0.00524	0.00812	CcSEcCtD
Zaleplon—TSPO—brainstem—malignant glioma	0.0052	0.029	CbGeAlD
Zaleplon—Vaginal inflammation—Temozolomide—malignant glioma	0.00515	0.00797	CcSEcCtD
Zaleplon—Pulmonary embolism—Temozolomide—malignant glioma	0.00515	0.00797	CcSEcCtD
Zaleplon—Urinary incontinence—Carmustine—malignant glioma	0.00514	0.00796	CcSEcCtD
Zaleplon—Depressed level of consciousness—Carmustine—malignant glioma	0.00514	0.00796	CcSEcCtD
Zaleplon—TSPO—retina—malignant glioma	0.00501	0.028	CbGeAlD
Zaleplon—Neuropathy—Carmustine—malignant glioma	0.005	0.00774	CcSEcCtD
Zaleplon—GABRA2—telencephalon—malignant glioma	0.00498	0.0278	CbGeAlD
Zaleplon—Depressed level of consciousness—Temozolomide—malignant glioma	0.00497	0.0077	CcSEcCtD
Zaleplon—Urinary incontinence—Temozolomide—malignant glioma	0.00497	0.0077	CcSEcCtD
Zaleplon—Vaginal infection—Temozolomide—malignant glioma	0.00486	0.00753	CcSEcCtD
Zaleplon—Neuropathy—Temozolomide—malignant glioma	0.00483	0.00748	CcSEcCtD
Zaleplon—GABRA1—telencephalon—malignant glioma	0.00481	0.0269	CbGeAlD
Zaleplon—Dry eye—Temozolomide—malignant glioma	0.00475	0.00736	CcSEcCtD
Zaleplon—Abnormal vision—Carmustine—malignant glioma	0.00464	0.00719	CcSEcCtD
Zaleplon—Mental disability—Carmustine—malignant glioma	0.00462	0.00716	CcSEcCtD
Zaleplon—TSPO—telencephalon—malignant glioma	0.00461	0.0257	CbGeAlD
Zaleplon—Abnormal vision—Temozolomide—malignant glioma	0.00449	0.00695	CcSEcCtD
Zaleplon—Mental disability—Temozolomide—malignant glioma	0.00446	0.00692	CcSEcCtD
Zaleplon—Thrombophlebitis—Carmustine—malignant glioma	0.00446	0.00692	CcSEcCtD
Zaleplon—Diabetes mellitus—Carmustine—malignant glioma	0.00444	0.00688	CcSEcCtD
Zaleplon—Swelling—Carmustine—malignant glioma	0.00438	0.00679	CcSEcCtD
Zaleplon—Ear pain—Temozolomide—malignant glioma	0.00438	0.00678	CcSEcCtD
Zaleplon—Thrombophlebitis—Temozolomide—malignant glioma	0.00431	0.00668	CcSEcCtD
Zaleplon—GABRG2—medulla oblongata—malignant glioma	0.00428	0.0239	CbGeAlD
Zaleplon—GABRB2—medulla oblongata—malignant glioma	0.00428	0.0239	CbGeAlD
Zaleplon—Eye pain—Carmustine—malignant glioma	0.00428	0.00663	CcSEcCtD
Zaleplon—Gastroenteritis—Temozolomide—malignant glioma	0.00421	0.00653	CcSEcCtD
Zaleplon—GABRB3—telencephalon—malignant glioma	0.00419	0.0234	CbGeAlD
Zaleplon—Deafness—Temozolomide—malignant glioma	0.00417	0.00647	CcSEcCtD
Zaleplon—Vascular purpura—Temozolomide—malignant glioma	0.00417	0.00647	CcSEcCtD
Zaleplon—Eye pain—Temozolomide—malignant glioma	0.00414	0.00641	CcSEcCtD
Zaleplon—Amnesia—Carmustine—malignant glioma	0.00411	0.00637	CcSEcCtD
Zaleplon—Amnesia—Temozolomide—malignant glioma	0.00398	0.00616	CcSEcCtD
Zaleplon—Thirst—Temozolomide—malignant glioma	0.00392	0.00608	CcSEcCtD
Zaleplon—GABRB2—midbrain—malignant glioma	0.00392	0.0218	CbGeAlD
Zaleplon—GABRG2—midbrain—malignant glioma	0.00392	0.0218	CbGeAlD
Zaleplon—Purpura—Temozolomide—malignant glioma	0.00387	0.006	CcSEcCtD
Zaleplon—Diplopia—Carmustine—malignant glioma	0.00386	0.00599	CcSEcCtD
Zaleplon—GABRG2—spinal cord—malignant glioma	0.00382	0.0213	CbGeAlD
Zaleplon—GABRB2—spinal cord—malignant glioma	0.00382	0.0213	CbGeAlD
Zaleplon—GABRA1—medulla oblongata—malignant glioma	0.00378	0.0211	CbGeAlD
Zaleplon—Diplopia—Temozolomide—malignant glioma	0.00373	0.00579	CcSEcCtD
Zaleplon—Face oedema—Carmustine—malignant glioma	0.00373	0.00578	CcSEcCtD
Zaleplon—Affect lability—Temozolomide—malignant glioma	0.00368	0.0057	CcSEcCtD
Zaleplon—Ataxia—Carmustine—malignant glioma	0.00363	0.00563	CcSEcCtD
Zaleplon—TSPO—medulla oblongata—malignant glioma	0.00362	0.0202	CbGeAlD
Zaleplon—Face oedema—Temozolomide—malignant glioma	0.00361	0.00559	CcSEcCtD
Zaleplon—Liver function test abnormal—Carmustine—malignant glioma	0.00357	0.00553	CcSEcCtD
Zaleplon—Mood swings—Temozolomide—malignant glioma	0.00354	0.00548	CcSEcCtD
Zaleplon—Ataxia—Temozolomide—malignant glioma	0.00351	0.00544	CcSEcCtD
Zaleplon—GABRA1—midbrain—malignant glioma	0.00346	0.0193	CbGeAlD
Zaleplon—Dry skin—Temozolomide—malignant glioma	0.00342	0.0053	CcSEcCtD
Zaleplon—Muscular weakness—Carmustine—malignant glioma	0.00341	0.00528	CcSEcCtD
Zaleplon—Breast disorder—Temozolomide—malignant glioma	0.00337	0.00523	CcSEcCtD
Zaleplon—GABRA1—spinal cord—malignant glioma	0.00337	0.0188	CbGeAlD
Zaleplon—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00336	0.00521	CcSEcCtD
Zaleplon—Dysphagia—Carmustine—malignant glioma	0.00334	0.00517	CcSEcCtD
Zaleplon—TSPO—midbrain—malignant glioma	0.00331	0.0185	CbGeAlD
Zaleplon—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00329	0.0051	CcSEcCtD
Zaleplon—Muscular weakness—Temozolomide—malignant glioma	0.00329	0.0051	CcSEcCtD
Zaleplon—GABRB3—medulla oblongata—malignant glioma	0.00329	0.0184	CbGeAlD
Zaleplon—TSPO—spinal cord—malignant glioma	0.00323	0.018	CbGeAlD
Zaleplon—Dysphagia—Temozolomide—malignant glioma	0.00323	0.005	CcSEcCtD
Zaleplon—Bronchitis—Temozolomide—malignant glioma	0.0031	0.00481	CcSEcCtD
Zaleplon—GABRG2—central nervous system—malignant glioma	0.0031	0.0173	CbGeAlD
Zaleplon—GABRB2—central nervous system—malignant glioma	0.0031	0.0173	CbGeAlD
Zaleplon—GABRB2—cerebellum—malignant glioma	0.00303	0.0169	CbGeAlD
Zaleplon—GABRG2—cerebellum—malignant glioma	0.00303	0.0169	CbGeAlD
Zaleplon—Dysuria—Temozolomide—malignant glioma	0.00302	0.00468	CcSEcCtD
Zaleplon—Hyperglycaemia—Carmustine—malignant glioma	0.00301	0.00467	CcSEcCtD
Zaleplon—GABRB3—midbrain—malignant glioma	0.00301	0.0168	CbGeAlD
Zaleplon—AOX1—cerebellum—malignant glioma	0.003	0.0167	CbGeAlD
Zaleplon—Pneumonia—Carmustine—malignant glioma	0.003	0.00464	CcSEcCtD
Zaleplon—Pollakiuria—Temozolomide—malignant glioma	0.00298	0.00462	CcSEcCtD
Zaleplon—Erectile dysfunction—Temozolomide—malignant glioma	0.00297	0.00461	CcSEcCtD
Zaleplon—Depression—Carmustine—malignant glioma	0.00297	0.0046	CcSEcCtD
Zaleplon—Photosensitivity reaction—Temozolomide—malignant glioma	0.00295	0.00456	CcSEcCtD
Zaleplon—Weight increased—Temozolomide—malignant glioma	0.00294	0.00455	CcSEcCtD
Zaleplon—GABRB3—spinal cord—malignant glioma	0.00293	0.0164	CbGeAlD
Zaleplon—Weight decreased—Temozolomide—malignant glioma	0.00292	0.00452	CcSEcCtD
Zaleplon—Neuropathy peripheral—Carmustine—malignant glioma	0.00292	0.00452	CcSEcCtD
Zaleplon—Hyperglycaemia—Temozolomide—malignant glioma	0.00291	0.00451	CcSEcCtD
Zaleplon—Stomatitis—Carmustine—malignant glioma	0.0029	0.0045	CcSEcCtD
Zaleplon—Pneumonia—Temozolomide—malignant glioma	0.00289	0.00448	CcSEcCtD
Zaleplon—Depression—Temozolomide—malignant glioma	0.00287	0.00445	CcSEcCtD
Zaleplon—GABRA2—central nervous system—malignant glioma	0.00283	0.0158	CbGeAlD
Zaleplon—Neuropathy peripheral—Temozolomide—malignant glioma	0.00282	0.00437	CcSEcCtD
Zaleplon—Stomatitis—Temozolomide—malignant glioma	0.00281	0.00435	CcSEcCtD
Zaleplon—GABRA2—cerebellum—malignant glioma	0.00277	0.0154	CbGeAlD
Zaleplon—GABRA1—central nervous system—malignant glioma	0.00274	0.0153	CbGeAlD
Zaleplon—Hepatobiliary disease—Temozolomide—malignant glioma	0.00272	0.00422	CcSEcCtD
Zaleplon—GABRA1—cerebellum—malignant glioma	0.00267	0.0149	CbGeAlD
Zaleplon—Hallucination—Carmustine—malignant glioma	0.00266	0.00412	CcSEcCtD
Zaleplon—Hypoaesthesia—Carmustine—malignant glioma	0.00266	0.00412	CcSEcCtD
Zaleplon—Oedema peripheral—Carmustine—malignant glioma	0.00263	0.00408	CcSEcCtD
Zaleplon—TSPO—central nervous system—malignant glioma	0.00262	0.0146	CbGeAlD
Zaleplon—Visual impairment—Carmustine—malignant glioma	0.00258	0.00399	CcSEcCtD
Zaleplon—Hallucination—Temozolomide—malignant glioma	0.00257	0.00398	CcSEcCtD
Zaleplon—Hypoaesthesia—Temozolomide—malignant glioma	0.00257	0.00398	CcSEcCtD
Zaleplon—TSPO—cerebellum—malignant glioma	0.00256	0.0143	CbGeAlD
Zaleplon—Oedema peripheral—Temozolomide—malignant glioma	0.00255	0.00394	CcSEcCtD
Zaleplon—Eye disorder—Carmustine—malignant glioma	0.0025	0.00387	CcSEcCtD
Zaleplon—Visual impairment—Temozolomide—malignant glioma	0.00249	0.00386	CcSEcCtD
Zaleplon—GABRG2—brain—malignant glioma	0.00246	0.0137	CbGeAlD
Zaleplon—GABRB2—brain—malignant glioma	0.00246	0.0137	CbGeAlD
Zaleplon—AOX1—brain—malignant glioma	0.00244	0.0136	CbGeAlD
Zaleplon—Eye disorder—Temozolomide—malignant glioma	0.00241	0.00374	CcSEcCtD
Zaleplon—Tinnitus—Temozolomide—malignant glioma	0.00241	0.00373	CcSEcCtD
Zaleplon—GABRB3—central nervous system—malignant glioma	0.00238	0.0133	CbGeAlD
Zaleplon—Alopecia—Carmustine—malignant glioma	0.00236	0.00366	CcSEcCtD
Zaleplon—Mental disorder—Carmustine—malignant glioma	0.00234	0.00363	CcSEcCtD
Zaleplon—Immune system disorder—Temozolomide—malignant glioma	0.00233	0.00362	CcSEcCtD
Zaleplon—Malnutrition—Carmustine—malignant glioma	0.00233	0.00361	CcSEcCtD
Zaleplon—GABRB3—cerebellum—malignant glioma	0.00233	0.013	CbGeAlD
Zaleplon—Chills—Temozolomide—malignant glioma	0.00232	0.00359	CcSEcCtD
Zaleplon—Alopecia—Temozolomide—malignant glioma	0.00228	0.00354	CcSEcCtD
Zaleplon—Mental disorder—Temozolomide—malignant glioma	0.00226	0.00351	CcSEcCtD
Zaleplon—Back pain—Carmustine—malignant glioma	0.00225	0.00349	CcSEcCtD
Zaleplon—Malnutrition—Temozolomide—malignant glioma	0.00225	0.00348	CcSEcCtD
Zaleplon—GABRA2—brain—malignant glioma	0.00225	0.0125	CbGeAlD
Zaleplon—Dysgeusia—Temozolomide—malignant glioma	0.0022	0.00341	CcSEcCtD
Zaleplon—Tremor—Carmustine—malignant glioma	0.00218	0.00338	CcSEcCtD
Zaleplon—Back pain—Temozolomide—malignant glioma	0.00218	0.00337	CcSEcCtD
Zaleplon—GABRA1—brain—malignant glioma	0.00217	0.0121	CbGeAlD
Zaleplon—Anaemia—Carmustine—malignant glioma	0.00215	0.00333	CcSEcCtD
Zaleplon—Agitation—Carmustine—malignant glioma	0.00214	0.00331	CcSEcCtD
Zaleplon—Tremor—Temozolomide—malignant glioma	0.00211	0.00326	CcSEcCtD
Zaleplon—Ill-defined disorder—Temozolomide—malignant glioma	0.00209	0.00323	CcSEcCtD
Zaleplon—TSPO—brain—malignant glioma	0.00208	0.0116	CbGeAlD
Zaleplon—Anaemia—Temozolomide—malignant glioma	0.00208	0.00322	CcSEcCtD
Zaleplon—Agitation—Temozolomide—malignant glioma	0.00207	0.0032	CcSEcCtD
Zaleplon—Angioedema—Temozolomide—malignant glioma	0.00206	0.00318	CcSEcCtD
Zaleplon—Malaise—Temozolomide—malignant glioma	0.00203	0.00314	CcSEcCtD
Zaleplon—Vertigo—Temozolomide—malignant glioma	0.00202	0.00313	CcSEcCtD
Zaleplon—Hypertension—Carmustine—malignant glioma	0.00201	0.00311	CcSEcCtD
Zaleplon—Palpitations—Temozolomide—malignant glioma	0.00199	0.00308	CcSEcCtD
Zaleplon—Chest pain—Carmustine—malignant glioma	0.00198	0.00307	CcSEcCtD
Zaleplon—Myalgia—Carmustine—malignant glioma	0.00198	0.00307	CcSEcCtD
Zaleplon—Anxiety—Carmustine—malignant glioma	0.00197	0.00306	CcSEcCtD
Zaleplon—Hypertension—Temozolomide—malignant glioma	0.00194	0.00301	CcSEcCtD
Zaleplon—Confusional state—Carmustine—malignant glioma	0.00192	0.00297	CcSEcCtD
Zaleplon—Arthralgia—Temozolomide—malignant glioma	0.00191	0.00297	CcSEcCtD
Zaleplon—Myalgia—Temozolomide—malignant glioma	0.00191	0.00297	CcSEcCtD
Zaleplon—Anxiety—Temozolomide—malignant glioma	0.00191	0.00296	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.0019	0.00295	CcSEcCtD
Zaleplon—Oedema—Carmustine—malignant glioma	0.0019	0.00294	CcSEcCtD
Zaleplon—Discomfort—Temozolomide—malignant glioma	0.00189	0.00293	CcSEcCtD
Zaleplon—GABRB3—brain—malignant glioma	0.00189	0.0105	CbGeAlD
Zaleplon—Dry mouth—Temozolomide—malignant glioma	0.00187	0.0029	CcSEcCtD
Zaleplon—Tachycardia—Carmustine—malignant glioma	0.00185	0.00287	CcSEcCtD
Zaleplon—Confusional state—Temozolomide—malignant glioma	0.00185	0.00287	CcSEcCtD
Zaleplon—Anaphylactic shock—Temozolomide—malignant glioma	0.00184	0.00284	CcSEcCtD
Zaleplon—Oedema—Temozolomide—malignant glioma	0.00184	0.00284	CcSEcCtD
Zaleplon—Anorexia—Carmustine—malignant glioma	0.00181	0.00281	CcSEcCtD
Zaleplon—Nervous system disorder—Temozolomide—malignant glioma	0.0018	0.00279	CcSEcCtD
Zaleplon—Skin disorder—Temozolomide—malignant glioma	0.00178	0.00276	CcSEcCtD
Zaleplon—Hypotension—Carmustine—malignant glioma	0.00177	0.00275	CcSEcCtD
Zaleplon—Hyperhidrosis—Temozolomide—malignant glioma	0.00177	0.00275	CcSEcCtD
Zaleplon—Anorexia—Temozolomide—malignant glioma	0.00175	0.00271	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00173	0.00268	CcSEcCtD
Zaleplon—Insomnia—Carmustine—malignant glioma	0.00172	0.00266	CcSEcCtD
Zaleplon—Paraesthesia—Carmustine—malignant glioma	0.00171	0.00264	CcSEcCtD
Zaleplon—Dyspnoea—Carmustine—malignant glioma	0.00169	0.00262	CcSEcCtD
Zaleplon—Somnolence—Carmustine—malignant glioma	0.00169	0.00262	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00167	0.00259	CcSEcCtD
Zaleplon—Insomnia—Temozolomide—malignant glioma	0.00166	0.00257	CcSEcCtD
Zaleplon—Decreased appetite—Carmustine—malignant glioma	0.00165	0.00256	CcSEcCtD
Zaleplon—Paraesthesia—Temozolomide—malignant glioma	0.00165	0.00255	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Carmustine—malignant glioma	0.00164	0.00254	CcSEcCtD
Zaleplon—Dyspnoea—Temozolomide—malignant glioma	0.00164	0.00254	CcSEcCtD
Zaleplon—Somnolence—Temozolomide—malignant glioma	0.00163	0.00253	CcSEcCtD
Zaleplon—Pain—Carmustine—malignant glioma	0.00162	0.00252	CcSEcCtD
Zaleplon—Constipation—Carmustine—malignant glioma	0.00162	0.00252	CcSEcCtD
Zaleplon—Dyspepsia—Temozolomide—malignant glioma	0.00162	0.0025	CcSEcCtD
Zaleplon—Decreased appetite—Temozolomide—malignant glioma	0.0016	0.00247	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00158	0.00246	CcSEcCtD
Zaleplon—Pain—Temozolomide—malignant glioma	0.00157	0.00243	CcSEcCtD
Zaleplon—Constipation—Temozolomide—malignant glioma	0.00157	0.00243	CcSEcCtD
Zaleplon—Feeling abnormal—Carmustine—malignant glioma	0.00157	0.00242	CcSEcCtD
Zaleplon—Gastrointestinal pain—Carmustine—malignant glioma	0.00155	0.00241	CcSEcCtD
Zaleplon—Feeling abnormal—Temozolomide—malignant glioma	0.00151	0.00234	CcSEcCtD
Zaleplon—Body temperature increased—Carmustine—malignant glioma	0.0015	0.00233	CcSEcCtD
Zaleplon—Abdominal pain—Carmustine—malignant glioma	0.0015	0.00233	CcSEcCtD
Zaleplon—Gastrointestinal pain—Temozolomide—malignant glioma	0.0015	0.00233	CcSEcCtD
Zaleplon—Urticaria—Temozolomide—malignant glioma	0.00146	0.00226	CcSEcCtD
Zaleplon—Abdominal pain—Temozolomide—malignant glioma	0.00145	0.00225	CcSEcCtD
Zaleplon—Body temperature increased—Temozolomide—malignant glioma	0.00145	0.00225	CcSEcCtD
Zaleplon—Asthenia—Carmustine—malignant glioma	0.00136	0.00211	CcSEcCtD
Zaleplon—Asthenia—Temozolomide—malignant glioma	0.00132	0.00204	CcSEcCtD
Zaleplon—Pruritus—Temozolomide—malignant glioma	0.0013	0.00201	CcSEcCtD
Zaleplon—Dizziness—Carmustine—malignant glioma	0.00126	0.00195	CcSEcCtD
Zaleplon—CYP3A4—central nervous system—malignant glioma	0.00122	0.0068	CbGeAlD
Zaleplon—Dizziness—Temozolomide—malignant glioma	0.00121	0.00188	CcSEcCtD
Zaleplon—Rash—Carmustine—malignant glioma	0.0012	0.00186	CcSEcCtD
Zaleplon—Dermatitis—Carmustine—malignant glioma	0.0012	0.00185	CcSEcCtD
Zaleplon—Headache—Carmustine—malignant glioma	0.00119	0.00184	CcSEcCtD
Zaleplon—Rash—Temozolomide—malignant glioma	0.00116	0.00179	CcSEcCtD
Zaleplon—Dermatitis—Temozolomide—malignant glioma	0.00116	0.00179	CcSEcCtD
Zaleplon—Headache—Temozolomide—malignant glioma	0.00115	0.00178	CcSEcCtD
Zaleplon—Nausea—Carmustine—malignant glioma	0.00113	0.00175	CcSEcCtD
Zaleplon—Nausea—Temozolomide—malignant glioma	0.00109	0.00169	CcSEcCtD
Zaleplon—GABRB2—Neuronal System—SLC6A3—malignant glioma	0.000352	0.00201	CbGpPWpGaD
Zaleplon—GABRA2—Neuronal System—BCHE—malignant glioma	0.000351	0.002	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—HES1—malignant glioma	0.00035	0.002	CbGpPWpGaD
Zaleplon—GABRB3—Neuronal System—BCHE—malignant glioma	0.000348	0.00199	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000347	0.00198	CbGpPWpGaD
Zaleplon—GABRG2—Neuronal System—BCHE—malignant glioma	0.000342	0.00195	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—APOD—malignant glioma	0.000338	0.00193	CbGpPWpGaD
Zaleplon—CYP3A5—Biological oxidations—GSTT1—malignant glioma	0.000336	0.00192	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—BCAN—malignant glioma	0.000333	0.0019	CbGpPWpGaD
Zaleplon—GABRB3—BDNF signaling pathway—BAD—malignant glioma	0.000331	0.00189	CbGpPWpGaD
Zaleplon—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—malignant glioma	0.000331	0.00189	CbGpPWpGaD
Zaleplon—GABRA2—Neuronal System—SLC6A3—malignant glioma	0.00033	0.00188	CbGpPWpGaD
Zaleplon—GABRB3—Neuronal System—SLC6A3—malignant glioma	0.000327	0.00187	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—RTEL1—malignant glioma	0.000326	0.00186	CbGpPWpGaD
Zaleplon—CYP3A7—Biological oxidations—GSTP1—malignant glioma	0.000322	0.00184	CbGpPWpGaD
Zaleplon—GABRG2—Neuronal System—SLC6A3—malignant glioma	0.000322	0.00183	CbGpPWpGaD
Zaleplon—GABRB3—BDNF signaling pathway—APC—malignant glioma	0.000321	0.00183	CbGpPWpGaD
Zaleplon—CYP3A7—Metapathway biotransformation—GSTP1—malignant glioma	0.000318	0.00181	CbGpPWpGaD
Zaleplon—GABRB3—BDNF signaling pathway—PTPN11—malignant glioma	0.000315	0.0018	CbGpPWpGaD
Zaleplon—CYP3A5—Biological oxidations—PTGS1—malignant glioma	0.000315	0.0018	CbGpPWpGaD
Zaleplon—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—malignant glioma	0.000311	0.00177	CbGpPWpGaD
Zaleplon—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—malignant glioma	0.000309	0.00176	CbGpPWpGaD
Zaleplon—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—malignant glioma	0.000303	0.00173	CbGpPWpGaD
Zaleplon—CYP3A4—Tryptophan metabolism—CAT—malignant glioma	0.000303	0.00173	CbGpPWpGaD
Zaleplon—GABRA1—Neuronal System—BCHE—malignant glioma	0.000299	0.00171	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—HIF1A—malignant glioma	0.000293	0.00167	CbGpPWpGaD
Zaleplon—AOX1—Disease—HEY2—malignant glioma	0.000282	0.00161	CbGpPWpGaD
Zaleplon—GABRA1—Neuronal System—SLC6A3—malignant glioma	0.000281	0.0016	CbGpPWpGaD
Zaleplon—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.000278	0.00158	CbGpPWpGaD
Zaleplon—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.000277	0.00158	CbGpPWpGaD
Zaleplon—AOX1—Disease—IDH1—malignant glioma	0.000276	0.00157	CbGpPWpGaD
Zaleplon—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000275	0.00157	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—IDH2—malignant glioma	0.000268	0.00153	CbGpPWpGaD
Zaleplon—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—malignant glioma	0.000265	0.00151	CbGpPWpGaD
Zaleplon—AOX1—Disease—HEY1—malignant glioma	0.000261	0.00149	CbGpPWpGaD
Zaleplon—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000261	0.00149	CbGpPWpGaD
Zaleplon—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.00026	0.00148	CbGpPWpGaD
Zaleplon—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.000259	0.00148	CbGpPWpGaD
Zaleplon—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.000259	0.00147	CbGpPWpGaD
Zaleplon—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.000258	0.00147	CbGpPWpGaD
Zaleplon—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.000254	0.00145	CbGpPWpGaD
Zaleplon—AOX1—Disease—HIST1H3B—malignant glioma	0.000254	0.00145	CbGpPWpGaD
Zaleplon—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.000253	0.00144	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—CYP2B6—malignant glioma	0.000252	0.00144	CbGpPWpGaD
Zaleplon—GABRB3—BDNF signaling pathway—RAF1—malignant glioma	0.000252	0.00144	CbGpPWpGaD
Zaleplon—GABRB2—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000249	0.00142	CbGpPWpGaD
Zaleplon—GABRB2—Ion channel transport—RAF1—malignant glioma	0.000246	0.0014	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—RTEL1—malignant glioma	0.000235	0.00134	CbGpPWpGaD
Zaleplon—GABRA2—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000234	0.00133	CbGpPWpGaD
Zaleplon—CYP3A5—Biological oxidations—GSTP1—malignant glioma	0.000233	0.00133	CbGpPWpGaD
Zaleplon—GABRB3—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000232	0.00132	CbGpPWpGaD
Zaleplon—AOX1—Disease—JAG2—malignant glioma	0.000232	0.00132	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—IDH1—malignant glioma	0.000231	0.00132	CbGpPWpGaD
Zaleplon—GABRA2—Ion channel transport—RAF1—malignant glioma	0.000231	0.00132	CbGpPWpGaD
Zaleplon—CYP3A5—Metapathway biotransformation—GSTP1—malignant glioma	0.00023	0.00131	CbGpPWpGaD
Zaleplon—GABRB3—Ion channel transport—RAF1—malignant glioma	0.000229	0.00131	CbGpPWpGaD
Zaleplon—GABRG2—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000228	0.0013	CbGpPWpGaD
Zaleplon—GABRB3—BDNF signaling pathway—CASP3—malignant glioma	0.000226	0.00129	CbGpPWpGaD
Zaleplon—GABRG2—Ion channel transport—RAF1—malignant glioma	0.000225	0.00128	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—SPHK1—malignant glioma	0.000223	0.00127	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—CYP2B6—malignant glioma	0.000223	0.00127	CbGpPWpGaD
Zaleplon—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	0.000222	0.00127	CbGpPWpGaD
Zaleplon—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	0.000221	0.00126	CbGpPWpGaD
Zaleplon—CYP3A4—Metapathway biotransformation—CYP2B6—malignant glioma	0.00022	0.00125	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—CYP2C18—malignant glioma	0.000219	0.00125	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000216	0.00123	CbGpPWpGaD
Zaleplon—GABRB2—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000209	0.00119	CbGpPWpGaD
Zaleplon—GABRB2—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000208	0.00119	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000203	0.00116	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000201	0.00115	CbGpPWpGaD
Zaleplon—GABRA1—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000199	0.00114	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000199	0.00113	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000198	0.00113	CbGpPWpGaD
Zaleplon—GABRA1—Ion channel transport—RAF1—malignant glioma	0.000197	0.00112	CbGpPWpGaD
Zaleplon—AOX1—Disease—H3F3A—malignant glioma	0.000196	0.00112	CbGpPWpGaD
Zaleplon—GABRA2—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000196	0.00112	CbGpPWpGaD
Zaleplon—GABRA2—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000195	0.00111	CbGpPWpGaD
Zaleplon—GABRB3—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000194	0.00111	CbGpPWpGaD
Zaleplon—GABRB3—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000194	0.0011	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	0.000193	0.0011	CbGpPWpGaD
Zaleplon—GABRG2—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000191	0.00109	CbGpPWpGaD
Zaleplon—GABRB2—Neuronal System—BRAF—malignant glioma	0.000191	0.00109	CbGpPWpGaD
Zaleplon—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	0.00019	0.00109	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—CXCL8—malignant glioma	0.00019	0.00109	CbGpPWpGaD
Zaleplon—GABRG2—Transmission across Chemical Synapses—RAF1—malignant glioma	0.00019	0.00108	CbGpPWpGaD
Zaleplon—GABRB3—BDNF signaling pathway—STAT3—malignant glioma	0.00019	0.00108	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000189	0.00108	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—COX8A—malignant glioma	0.000187	0.00107	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000186	0.00106	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000185	0.00106	CbGpPWpGaD
Zaleplon—AOX1—Disease—JAG1—malignant glioma	0.000185	0.00105	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—IL1B—malignant glioma	0.000183	0.00104	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—CASP3—malignant glioma	0.000182	0.00104	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000182	0.00104	CbGpPWpGaD
Zaleplon—AOX1—Disease—FBXW7—malignant glioma	0.000181	0.00103	CbGpPWpGaD
Zaleplon—GABRA2—Neuronal System—BRAF—malignant glioma	0.000179	0.00102	CbGpPWpGaD
Zaleplon—GABRB3—Neuronal System—BRAF—malignant glioma	0.000178	0.00101	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000177	0.00101	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—GSTT1—malignant glioma	0.000177	0.00101	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000176	0.001	CbGpPWpGaD
Zaleplon—GABRG2—Neuronal System—BRAF—malignant glioma	0.000175	0.000996	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000173	0.000986	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000173	0.000986	CbGpPWpGaD
Zaleplon—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	0.000167	0.000953	CbGpPWpGaD
Zaleplon—GABRA1—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000167	0.000952	CbGpPWpGaD
Zaleplon—GABRA1—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000166	0.000948	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PTGS1—malignant glioma	0.000166	0.000946	CbGpPWpGaD
Zaleplon—GABRB2—Neuronal System—MDM2—malignant glioma	0.00016	0.000912	CbGpPWpGaD
Zaleplon—GABRB2—Neuronal System—RAF1—malignant glioma	0.000159	0.000909	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—ASMT—malignant glioma	0.000159	0.000907	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000159	0.000906	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—GSTT1—malignant glioma	0.000156	0.000891	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—VEGFA—malignant glioma	0.000155	0.000882	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—BCHE—malignant glioma	0.000154	0.000879	CbGpPWpGaD
Zaleplon—GABRA1—Neuronal System—BRAF—malignant glioma	0.000153	0.00087	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—SLC5A5—malignant glioma	0.000152	0.000869	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000151	0.000862	CbGpPWpGaD
Zaleplon—GABRA2—Neuronal System—MDM2—malignant glioma	0.00015	0.000855	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—BCAN—malignant glioma	0.00015	0.000853	CbGpPWpGaD
Zaleplon—GABRA2—Neuronal System—RAF1—malignant glioma	0.000149	0.000852	CbGpPWpGaD
Zaleplon—GABRB3—Neuronal System—MDM2—malignant glioma	0.000149	0.00085	CbGpPWpGaD
Zaleplon—GABRB3—Neuronal System—RAF1—malignant glioma	0.000148	0.000847	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—PTGS1—malignant glioma	0.000146	0.000835	CbGpPWpGaD
Zaleplon—GABRG2—Neuronal System—MDM2—malignant glioma	0.000146	0.000834	CbGpPWpGaD
Zaleplon—GABRG2—Neuronal System—RAF1—malignant glioma	0.000146	0.000831	CbGpPWpGaD
Zaleplon—AOX1—Disease—CDKN2B—malignant glioma	0.000142	0.000809	CbGpPWpGaD
Zaleplon—AOX1—Disease—HES1—malignant glioma	0.000135	0.000772	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—COX8A—malignant glioma	0.000135	0.000771	CbGpPWpGaD
Zaleplon—AOX1—Disease—NCOR1—malignant glioma	0.000135	0.000768	CbGpPWpGaD
Zaleplon—GABRA1—SIDS Susceptibility Pathways—TNF—malignant glioma	0.000132	0.000756	CbGpPWpGaD
Zaleplon—AOX1—Disease—PDGFRA—malignant glioma	0.000129	0.000735	CbGpPWpGaD
Zaleplon—GABRA1—Neuronal System—MDM2—malignant glioma	0.000128	0.000729	CbGpPWpGaD
Zaleplon—GABRA1—Neuronal System—RAF1—malignant glioma	0.000127	0.000727	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—GSTP1—malignant glioma	0.000123	0.0007	CbGpPWpGaD
Zaleplon—GABRB3—BDNF signaling pathway—AKT1—malignant glioma	0.000122	0.000699	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—IDH2—malignant glioma	0.000121	0.000688	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—CAT—malignant glioma	0.000119	0.000681	CbGpPWpGaD
Zaleplon—AOX1—Disease—TERT—malignant glioma	0.000119	0.000677	CbGpPWpGaD
Zaleplon—AOX1—Disease—HLA-A—malignant glioma	0.000119	0.000677	CbGpPWpGaD
Zaleplon—AOX1—Disease—PDGFB—malignant glioma	0.000116	0.00066	CbGpPWpGaD
Zaleplon—AOX1—Disease—FGFR1—malignant glioma	0.000115	0.000657	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—ASMT—malignant glioma	0.000115	0.000656	CbGpPWpGaD
Zaleplon—AOX1—Disease—HIF1A—malignant glioma	0.000113	0.000647	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CYP2B6—malignant glioma	0.000113	0.000646	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—NCOR1—malignant glioma	0.000113	0.000643	CbGpPWpGaD
Zaleplon—AOX1—Disease—CAV1—malignant glioma	0.00011	0.000626	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—RTEL1—malignant glioma	0.000109	0.000624	CbGpPWpGaD
Zaleplon—CYP3A4—Biological oxidations—GSTP1—malignant glioma	0.000108	0.000617	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—BCAN—malignant glioma	0.000108	0.000617	CbGpPWpGaD
Zaleplon—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	0.000107	0.000609	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—IDH1—malignant glioma	0.000104	0.000591	CbGpPWpGaD
Zaleplon—AOX1—Disease—BAD—malignant glioma	0.000103	0.000589	CbGpPWpGaD
Zaleplon—AOX1—Disease—NOTCH1—malignant glioma	0.000102	0.000583	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—SPHK1—malignant glioma	0.0001	0.000572	CbGpPWpGaD
Zaleplon—AOX1—Disease—CD80—malignant glioma	0.0001	0.000571	CbGpPWpGaD
Zaleplon—AOX1—Disease—APC—malignant glioma	9.99e-05	0.00057	CbGpPWpGaD
Zaleplon—AOX1—Disease—EGF—malignant glioma	9.88e-05	0.000563	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CYP2C18—malignant glioma	9.83e-05	0.00056	CbGpPWpGaD
Zaleplon—AOX1—Disease—PTPN11—malignant glioma	9.82e-05	0.00056	CbGpPWpGaD
Zaleplon—AOX1—Disease—BRAF—malignant glioma	9.39e-05	0.000536	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—CAV1—malignant glioma	9.19e-05	0.000524	CbGpPWpGaD
Zaleplon—AOX1—Disease—AKT2—malignant glioma	9.14e-05	0.000522	CbGpPWpGaD
Zaleplon—AOX1—Disease—PIK3CD—malignant glioma	8.79e-05	0.000501	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—IDH2—malignant glioma	8.71e-05	0.000497	CbGpPWpGaD
Zaleplon—GABRB2—Transmembrane transport of small molecules—RAF1—malignant glioma	8.57e-05	0.000489	CbGpPWpGaD
Zaleplon—AOX1—Disease—FGF2—malignant glioma	8.41e-05	0.00048	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PIK3CG—malignant glioma	8.37e-05	0.000477	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CYP2B6—malignant glioma	8.19e-05	0.000467	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PPARG—malignant glioma	8.08e-05	0.000461	CbGpPWpGaD
Zaleplon—GABRA2—Transmembrane transport of small molecules—RAF1—malignant glioma	8.03e-05	0.000458	CbGpPWpGaD
Zaleplon—GABRB3—Transmembrane transport of small molecules—RAF1—malignant glioma	7.98e-05	0.000455	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GSTT1—malignant glioma	7.95e-05	0.000453	CbGpPWpGaD
Zaleplon—AOX1—Disease—MDM2—malignant glioma	7.87e-05	0.000449	CbGpPWpGaD
Zaleplon—AOX1—Disease—RAF1—malignant glioma	7.84e-05	0.000447	CbGpPWpGaD
Zaleplon—GABRG2—Transmembrane transport of small molecules—RAF1—malignant glioma	7.84e-05	0.000447	CbGpPWpGaD
Zaleplon—AOX1—Disease—ERBB2—malignant glioma	7.76e-05	0.000443	CbGpPWpGaD
Zaleplon—AOX1—Disease—PIK3CB—malignant glioma	7.66e-05	0.000437	CbGpPWpGaD
Zaleplon—AOX1—Disease—PTGS2—malignant glioma	7.59e-05	0.000433	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—IDH1—malignant glioma	7.49e-05	0.000427	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PTGS1—malignant glioma	7.45e-05	0.000425	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PIK3CD—malignant glioma	7.36e-05	0.00042	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—SPHK1—malignant glioma	7.25e-05	0.000414	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CYP2C18—malignant glioma	7.1e-05	0.000405	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—BCHE—malignant glioma	6.92e-05	0.000395	CbGpPWpGaD
Zaleplon—GABRA1—Transmembrane transport of small molecules—RAF1—malignant glioma	6.85e-05	0.000391	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—SLC5A5—malignant glioma	6.84e-05	0.00039	CbGpPWpGaD
Zaleplon—AOX1—Disease—PTEN—malignant glioma	6.62e-05	0.000377	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PIK3CB—malignant glioma	6.41e-05	0.000366	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PTGS2—malignant glioma	6.35e-05	0.000362	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—COX8A—malignant glioma	6.29e-05	0.000359	CbGpPWpGaD
Zaleplon—AOX1—Disease—STAT3—malignant glioma	5.92e-05	0.000338	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GSTT1—malignant glioma	5.74e-05	0.000328	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PTEN—malignant glioma	5.54e-05	0.000316	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—GSTP1—malignant glioma	5.51e-05	0.000314	CbGpPWpGaD
Zaleplon—AOX1—Disease—MYC—malignant glioma	5.5e-05	0.000314	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PTGS1—malignant glioma	5.38e-05	0.000307	CbGpPWpGaD
Zaleplon—AOX1—Disease—EGFR—malignant glioma	5.38e-05	0.000307	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CAT—malignant glioma	5.36e-05	0.000306	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—ASMT—malignant glioma	5.34e-05	0.000305	CbGpPWpGaD
Zaleplon—AOX1—Disease—KRAS—malignant glioma	5.08e-05	0.00029	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—NCOR1—malignant glioma	5.06e-05	0.000289	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—BCAN—malignant glioma	5.03e-05	0.000287	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—BCHE—malignant glioma	5e-05	0.000285	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—SLC5A5—malignant glioma	4.94e-05	0.000282	CbGpPWpGaD
Zaleplon—AOX1—Disease—PIK3CA—malignant glioma	4.67e-05	0.000266	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—CAV1—malignant glioma	4.13e-05	0.000235	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—IDH2—malignant glioma	4.05e-05	0.000231	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—GSTP1—malignant glioma	3.98e-05	0.000227	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—PIK3CA—malignant glioma	3.91e-05	0.000223	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CAT—malignant glioma	3.87e-05	0.000221	CbGpPWpGaD
Zaleplon—AOX1—Disease—AKT1—malignant glioma	3.81e-05	0.000218	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CYP2B6—malignant glioma	3.81e-05	0.000217	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PIK3CG—malignant glioma	3.76e-05	0.000214	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—NCOR1—malignant glioma	3.66e-05	0.000209	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PPARG—malignant glioma	3.63e-05	0.000207	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—IDH1—malignant glioma	3.48e-05	0.000199	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—SPHK1—malignant glioma	3.37e-05	0.000192	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PIK3CD—malignant glioma	3.3e-05	0.000188	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CYP2C18—malignant glioma	3.3e-05	0.000188	CbGpPWpGaD
Zaleplon—AOX1—Metabolism—AKT1—malignant glioma	3.19e-05	0.000182	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—CAV1—malignant glioma	2.98e-05	0.00017	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PIK3CB—malignant glioma	2.88e-05	0.000164	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PTGS2—malignant glioma	2.85e-05	0.000163	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PIK3CG—malignant glioma	2.72e-05	0.000155	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GSTT1—malignant glioma	2.67e-05	0.000152	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PPARG—malignant glioma	2.62e-05	0.00015	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PTGS1—malignant glioma	2.5e-05	0.000143	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PTEN—malignant glioma	2.49e-05	0.000142	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PIK3CD—malignant glioma	2.39e-05	0.000136	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—BCHE—malignant glioma	2.33e-05	0.000133	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—SLC5A5—malignant glioma	2.3e-05	0.000131	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PIK3CB—malignant glioma	2.08e-05	0.000119	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PTGS2—malignant glioma	2.06e-05	0.000118	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—GSTP1—malignant glioma	1.85e-05	0.000106	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CAT—malignant glioma	1.8e-05	0.000103	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PTEN—malignant glioma	1.8e-05	0.000103	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—PIK3CA—malignant glioma	1.76e-05	0.0001	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—NCOR1—malignant glioma	1.7e-05	9.7e-05	CbGpPWpGaD
Zaleplon—CYP3A7—Metabolism—AKT1—malignant glioma	1.43e-05	8.18e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—CAV1—malignant glioma	1.39e-05	7.91e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—PIK3CA—malignant glioma	1.27e-05	7.24e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.26e-05	7.2e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PPARG—malignant glioma	1.22e-05	6.95e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.11e-05	6.33e-05	CbGpPWpGaD
Zaleplon—CYP3A5—Metabolism—AKT1—malignant glioma	1.04e-05	5.91e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PIK3CB—malignant glioma	9.68e-06	5.52e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PTGS2—malignant glioma	9.59e-06	5.47e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PTEN—malignant glioma	8.36e-06	4.77e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—PIK3CA—malignant glioma	5.9e-06	3.37e-05	CbGpPWpGaD
Zaleplon—CYP3A4—Metabolism—AKT1—malignant glioma	4.82e-06	2.75e-05	CbGpPWpGaD
